Increased expression of receptor tyrosine protein kinase erbB-3, also known as human epidermal growth factor receptor 3 (HER3), a member of the EGFR family of receptor tyrosine kinases, was described as a marker of poor prognosis in melanoma [65]. The gene discussed is ERBB3; the disease is melanoma.